NAPP Logo
  • NAPP logo
  • About Us
  • Products
  • Working at Napp
    • Current vacancies
  • Partnering
    • Commercial partnering
    • Joint working
  • Education
    • Science Ambassador Scheme
    • NAPP Academy
  • Media
    • News
    • Press Releases
  • Contact
  • Home
  • About Us
  • Products
  • Working at Napp
  • Partnering
  • Education
  • Media
  • Contact

Press Releases

The below press releases have been approved for communication with medical press and media. For general Napp news, please visit our News page.

Image for Type 2 Diabetics miss out on a recommended annual kidney test which can signal irreversible damage that may lead to fatal complications, survey reveals
Type 2 Diabetics miss out on a recommended annual kidney test which can signal irreversible damage that may lead to fatal complications, survey reveals

February 20, 2020

Image for Type 2 Diabetics miss out on a recommended annual kidney test which can signal irreversible damage that may lead to fatal complications, survey reveals

Type 2 Diabetics miss out on a recommended annual kidney test which can signal irreversible damage that may lead to fatal complications, survey reveals

February 20, 2020

The urine test, which identifies early markers of kidney damage, is not routinely carried out by GPs and nurses in annual reviews, mainly because many patients are reluctant to provide a urine samplei    CAMBRIDGE, UK: 20.02.20 – A new UK-wide survey, conducted by Napp Pharmaceuticals, suggests that over half (54%, n=403) of GPs and nurses who treat patients with type 2 diabetes (T2D) do not carry out …
Read More
Image for Statement on the Public Health England Review on prescribed medicines that may cause dependence or withdrawal
Statement on the Public Health England Review on prescribed medicines that may cause dependence or withdrawal

September 10, 2019

Image for Statement on the Public Health England Review on prescribed medicines that may cause dependence or withdrawal
Statement on the Public Health England Review on prescribed medicines that may cause dependence or withdrawal

September 10, 2019

Image for CREDENCE Subgroup Analysis Finds Significant Reduction of Major Cardiovascular Events and Kidney Failure in Patients with Type 2 Diabetes and Chronic Kidney Disease
CREDENCE Subgroup Analysis Finds Significant Reduction of Major Cardiovascular Events and Kidney Failure in Patients with Type 2 Diabetes and Chronic Kidney Disease

June 12, 2019

Image for CREDENCE Subgroup Analysis Finds Significant Reduction of Major Cardiovascular Events and Kidney Failure in Patients with Type 2 Diabetes and Chronic Kidney Disease
CREDENCE Subgroup Analysis Finds Significant Reduction of Major Cardiovascular Events and Kidney Failure in Patients with Type 2 Diabetes and Chronic Kidney Disease

June 12, 2019

Image for Improving support for people who are prescribed medicines that have the potential to cause addiction, dependence or withdrawal symptoms
Improving support for people who are prescribed medicines that have the potential to cause addiction, dependence or withdrawal symptoms

April 30, 2019

Image for Improving support for people who are prescribed medicines that have the potential to cause addiction, dependence or withdrawal symptoms
Improving support for people who are prescribed medicines that have the potential to cause addiction, dependence or withdrawal symptoms

April 30, 2019

View all press releases

Stay connected

  • Legal
  • Cookie Policy
  • Privacy Notice
  • Registered Company
  • Modern Slavery Statement
  • Tax Strategy
  • Group Pension Scheme
  • Statement of Investment Principles
© 2020 NAPP Pharmaceuticals Limited
Last updated: May 2019

You are now leaving napp.co.uk. Napp does not accept any responsibility for the third party site.

Please click "Continue to external link" if you want to proceed.

Back to s://napp.co.uk
Continue to external link

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Settings. More Info. 

Napp
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Please enable Strictly Necessary Cookies first so that we can save your preferences!

Cookie Policy

More information about our Cookie Policy